Junichi Matsubara

3PUBLICATIONS
14CO-AUTHORS
PharmacogenomicsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 18, 2025
The nationwide survey of Japanese public opinion about off-label use of anticancer drugs recommended by comprehensive genomic profiling.

Junichi Matsubara, Kumi Mukai, Manabu Muto

|Feb 03, 2025
The E2F4 transcriptional repressor is a key mechanistic regulator of colon cancer resistance to irinotecan (CPT-11).

Junichi Matsubara, Yong Fuga Li, Sanjay Koul

Pageof 1